Medical technologists have fashioned synthetic nanoparticles to track down cancerous cells and to enable medics to differentiate cancerous cells from healthy cells. The technique should enable better targeted treatments.
As the sun continues to shine down intensely over the northern hemisphere renewed concerns have arisen about skin cancer risks. A German company has recently reiterated best practices for keeping safe during the summer.
Studies have taken place in Canada whereby magnetic bacteria are used to power nano-devices, to help ferry anti-cancer medicines to sites of tumors. Such devices offer faster and more precise drug delivery.
Technologists and medics have come together to devise nano-sized robots to deliver drugs accurately to different sites of infection within the human body. The main purpose is as a drug delivery system for anti-cancer medications.
A new global study has revealed variations in the rate of skin cancer around the world. The key variations relate to geographical and socio-economic factors, which make the disease more or less common.
Shares of Immunomedics (NASDAQ: IMMU) took a nosedive yesterday after the American Society of Clinical Oncology (ASCO) announced that it had prohibited the cancer drug developing company from presenting at the prestigious and highly publicized conference.
Personalized medicines have received a great deal of attention, where medicines are fashioned for particular patients. Now the first major study indicates that these medicines are demonstrably effective.
A new study suggests women who are prescribed hormonal drugs for up to 15 years after an incident of breast cancer have a far greater chance of avoiding the cancer returning compared with those who do not take the drugs.
A "cure" for cancer remains elusive. However, methods to detect cancer early and to administer treatment continue to advance. The latest is a new implant designed to spot cancerous cells before they develop into tumours.